Blood test may predict COVID-19 danger in transplant patients

NCT ID NCT04369456

Completed Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Nice Source: ClinicalTrials.gov ↗

First seen Apr 02, 2026 · Last updated May 04, 2026 · Updated 3 times

Summary

This study looked at whether a blood test measuring a specific immune marker (IL-6) could predict how severe COVID-19 would become in kidney transplant patients. Researchers followed 52 patients with mild-to-moderate symptoms to see if the test could identify those at higher risk of needing intensive care or dying. The goal was to find a way to guide treatment early on.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONAVIRUS INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

APHM

Marseille, 13000, France
APHP

Paris, 75000, France
Lyon Univerity Hospital

Lyon, 69000, France
Montpellier University Hospital

Montpellier, 34000, France
Saint Etienne University Hospital

Saint-Etienne, 42000, France
Strasbourg Univeristy Hospital

Strasbourg, 67000, France
University Nice Hospital

Nice, 06000, France

Conditions

Explore the condition pages connected to this study.

CORONAVIRUS INFECTION KIDNEY TRANSPLANT; COMPLICATIONS KIDNEY TRANSPLANT; COMPLICATIONS